Apellis Pharmaceuticals, INC. (APLS) — DEF 14A Filings

All DEF 14A filings from Apellis Pharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Apellis Pharma DEF 14A: Executive Compensation Details — Apr 23, 2025 Risk: low
Apellis Pharmaceuticals, Inc. filed a DEF 14A on April 23, 2025, detailing executive compensation and equity awards for the fiscal years ending December 31, 202
Apellis Pharmaceuticals, Inc. Files Definitive Proxy Statement — Apr 26, 2024 Risk:
Apellis Pharmaceuticals, Inc. (APLS) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Apellis Pharmaceuticals, Inc. filed a Definitive Proxy St

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX